Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Si-Bone (SIBN) Change in Accured Expenses (2017 - 2025)

Historic Change in Accured Expenses for Si-Bone (SIBN) over the last 9 years, with Q3 2025 value amounting to $1.5 million.

  • Si-Bone's Change in Accured Expenses fell 3972.55% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 4357.93%. This contributed to the annual value of $1.9 million for FY2024, which is 5092.59% down from last year.
  • According to the latest figures from Q3 2025, Si-Bone's Change in Accured Expenses is $1.5 million, which was down 3972.55% from $962000.0 recorded in Q2 2025.
  • In the past 5 years, Si-Bone's Change in Accured Expenses registered a high of $3.9 million during Q4 2023, and its lowest value of -$5.7 million during Q1 2024.
  • In the last 5 years, Si-Bone's Change in Accured Expenses had a median value of $1.1 million in 2022 and averaged $357842.1.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first soared by 1050000.0% in 2021, then plummeted by 6303.34% in 2022.
  • Over the past 5 years, Si-Bone's Change in Accured Expenses (Quarter) stood at $1.4 million in 2021, then skyrocketed by 63.51% to $2.3 million in 2022, then soared by 68.09% to $3.9 million in 2023, then fell by 14.13% to $3.3 million in 2024, then tumbled by 53.58% to $1.5 million in 2025.
  • Its Change in Accured Expenses stands at $1.5 million for Q3 2025, versus $962000.0 for Q2 2025 and -$4.4 million for Q1 2025.